Meftinib 250mg Tablet
Marketer
Ind Swift Laboratories Ltd
Salt Composition
Gefitinib (250mg)
Overview Meftinib 250mg Tablet
Afatinib 250mg tablets are indicated for treating metastatic non-small cell lung cancer in patients with abnormal epidermal growth factor receptor (EGFR) genes and no prior cancer therapy. Dosage should strictly follow your physician's instructions, continuing treatment for the prescribed duration, which depends on individual response. Regular liver function monitoring may be recommended. Common adverse reactions include nausea, diarrhea, dry skin, and appetite loss; increased fluid intake can mitigate some side effects. Report any persistent or worsening side effects, particularly oral ulcers, visual disturbances, or respiratory issues. Women should employ effective contraception throughout treatment and for one month post-treatment to prevent pregnancy. Disclose all other medications you are currently using to your doctor.
Primary Ingredients of Meftinib 250mg Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Meftinib 250mg Tablet
Lung cancer (non-small cell type)
Major Benefits of Meftinib 250mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 250mg Meftinib tablet whole; avoid chewing, crushing, or breaking it. While food isn't required, consistent timing is recommended for optimal results.
Common Side effects of Meftinib 250mg Tablet:
- Diarrhea
- Dry skin
- Loss of appetite
- Nausea
- Rash
- Vomiting
- Weakness
- Weight loss
- Eating disorder
- Allergic reaction
How to use Meftinib 250mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the 250mg Meftinib tablet whole; avoid chewing, crushing, or fracturing it. While consumption with or without food is acceptable, consistent daily timing is recommended.
How Meftinib 250mg Tablet works:
Mefitinib 250mg tablets are a cancer treatment that inhibits the activity of a faulty protein responsible for cancer cell proliferation, thus impeding or slowing tumor growth.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol consumption and Meftinib 250mg tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Taking Meftinib 250mg tablets during pregnancy poses a confirmed risk to the fetus. Its use is strongly discouraged except in extreme circumstances where a physician deems the potential benefits outweigh the known hazards. Always seek medical advice before using this medication.
Breast feedingCONSULT YOUR DOCTOR
The use of 250mg Meftinib tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking a 250mg Meftinib tablet may impair driving ability due to potential adverse effects.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Meftinib 250mg tablets. Dosage modification may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of 250mg Meftinib tablets in individuals with hepatic impairment is likely safe. Existing evidence indicates dose modification may be unnecessary; however, physician consultation is advised.
What if you forget to take Meftinib 250mg Tablet :
Omit any missed 250mg Meftinib Tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Meftinib 250mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Quinazoline amines |
| Developing Habits | No. |
| Type of Therapy | Cancer Medications |
3,018 People bought this recently